Soaring Demand Set to Propel Hormonal Intrauterine Devices (IUDs) Market to $4.29 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Hormonal Intrauterine Devices (IUDs) Market Through 2025?
In recent times, there has been a significant expansion in the market size of hormonal intrauterine devices (iuds). Predictions indicate that it will increase from $2.61 billion in 2024 to $2.87 billion in 2025, with a compound annual growth rate (CAGR) of 10.2%. The accelerated growth during the historical period can be ascribed to the evolution of more secure and efficient hormonal formulations, amplified demand for enduring birth control solutions, ascending endorsements from healthcare providers, heightened awareness about contraceptive alternatives amongst the public, and progress in medical technology and device design.

What's the Projected Size of the Global Hormonal Intrauterine Devices (IUDs) Market by 2029?
The market size for hormonal intrauterine devices (IUDs) is anticipated to experience a swift expansion in the forthcoming years. By 2029, it's predicted to reach a sizeable $4.29 billion, exhibiting a compound annual growth rate (CAGR) of 10.6%. Factors driving growth during this predictive period include the surge in awareness about contraceptive options, a mounting preference for long-acting reversible contraception, enhancements in the safety and efficacy of the devices, an increasing focus on personalized healthcare, and enlarged accessibility via healthcare providers. Key trends for the forecast period comprise advancements in device technology, growing personalization of contraceptive selections, expansion in patient-oriented healthcare models, escalating demand for green, sustainable products, and the invention of new contraceptive products.

View the full report here:
https://www.thebusinessresearchcompany.com/report/hormonal-intrauterine-devices-iuds-global-market-report

Top Growth Drivers in the Hormonal Intrauterine Devices (IUDs) Industry: What's Accelerating the Market?
The hormonal intrauterine devices market is predicted to expand due to an uptick in unwanted pregnancies. These are pregnancies that were either not planned or not wanted at the time they occurred. There are a variety of causes for such pregnancies including contraceptive failure, inadequate access to birth control, improper use of contraception, or instances of sexual violence. Insufficient access to effective birth control methods enhances the risk of unwanted pregnancies as it restricts individuals' autonomy over their reproductive choices. Hormonal IUDs are highly effective in deterring pregnancies, having a less than 1% failure rate. They offer a long-term solution (3 to 7 years, depending on the model) and are a dependable choice for those wanting to prevent unplanned pregnancies. For example, the Office for Health Improvement & Disparities, a UK government body within the UK's Department of Health and Social Care, reported in August 2023 that between January and June 2022, England and Wales residents underwent 123,219 abortions-an astonishing rise of 17% compared to the same timeframe in 2021. This rise in unwanted pregnancies is subsequently propelling the growth of the hormonal intrauterine devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19091&type=smp

What Are the Key Trends Driving Hormonal Intrauterine Devices (IUDs) Market Growth?
Leading firms in the hormonal intrauterine devices market are concentrating on the creation of innovative items, such as levonorgestrel-releasing intrauterine systems, aiming for personalised contraceptive options for females. These are hormonal intrauterine devices, known as LNG-IUS, that dispense a consistent amount of levonorgestrel, a synthetic progestin, into the uterus. This hormone increases the thickness of the cervical mucus and changes the lining of the uterus, preventing sperm from getting to the egg. As an illustration, in November 2022, Medicines360, an American pharmaceutical entity striving to enhance women's accessibility to vital medicines and health items, launched LILETTA, approved by the U.S. Food and Drug Administration (FDA). It is one of the most durable hormonal IUDs in the U.S., approved for a maximum of 8 years for contraception and a maximum of 5 years for heavy menstrual bleeding treatment. LILETTA is incredibly effective, with a prevention rate of roughly 99% across various populations. The device is user-friendly, designed for easy placement on the consultation day, and can be removed anytime by a healthcare professional. LILETTA is available through prescription at a reduced price via the 340B drug pricing program, in line with Medicines360's goal of enhancing women's healthcare access.

What Are the Main Segments in the Hormonal Intrauterine Devices (IUDs) Market?
The hormonal intrauterine devices (iuds) market covered in this report is segmented -

1) By Type: 13 Milligram Hormonal Intrauterine Devices, 19 Milligram Hormonal Intrauterine Devices, 52 Milligram Hormonal Intrauterine Devices
2) By Device Design: Framed Intrauterine Devices, Frameless Intrauterine Devices
3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices, Progesterone Releasing Intrauterine Devices
4) By Application: Age 20-24, Age 25-34, Age 35-44, Other Applications

Subsegments:
1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs, Specialty 13 Mg IUDs For Specific Conditions
2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs, Specialty 19 Mg IUDs For Specific Conditions
3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs, Extended-Release 52 Mg IUDs, Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19091&type=smp

Which Top Companies are Driving Growth in the Hormonal Intrauterine Devices (IUDs) Market?
Major companies operating in the hormonal intrauterine devices (IUDs) market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Bharat Serums and Vaccines Limited, Teva UK Limited, EurimPharm Produktions GmbH, HRA Pharma SAS, Medicines360, Hll Lifecare Limited, Pregna International Ltd., Allergan plc, Actavis Inc., DKT WomanCare Global, CrossBay Medical Inc., SMB Corporation of India, Oy Leiras, OCON Healthcare

Which Regions Will Dominate the Hormonal Intrauterine Devices (IUDs) Market Through 2029?
North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (IUDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19091

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.